lunes, 12 de julio de 2021

Accelerating the design of minibinder therapeutics resilient to SARS-CoV-2 mutations

Accelerating the design of minibinder therapeutics resilient to SARS-CoV-2 mutations

No hay comentarios:

Publicar un comentario